Fax: (301) 295-3627
Original Article
You have full text access to this OnlineOpen article
Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system†
Article first published online: 28 JUL 2003
DOI: 10.1002/cncr.11604
Copyright © 2003 American Cancer Society
Additional Information
How to Cite
Jatoi, I., Becher, H. and Leake, C. R. (2003), Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system. Cancer, 98: 894–899. doi: 10.1002/cncr.11604
- †
The opinions expressed in this article represent the private views of the authors and should not be construed as reflecting the official views of the Departments of the Army, Air Force, or Defense.
Publication History
- Issue published online: 20 AUG 2003
- Article first published online: 28 JUL 2003
- Manuscript Accepted: 29 MAY 2003
- Manuscript Revised: 23 MAY 2003
- Manuscript Received: 18 FEB 2003
REFERENCES
- 1. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst. 2002; 94: 471–473.
- 2, . Recent trends in breast cancer mortality among White and Black US women. Am J Public Health. 1997; 87: 775–781.
- 3, , , et al. Racial differences in survival from breast cancer. JAMA. 1994; 272: 947–954.
- 4, , , . Tumor biologic factors and breast cancer prognosis among White, Hispanic, and Black women in the United States. J Natl Cancer Inst. 1994; 86: 705–712.
- 5, , . Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002; 94: 90–96.
- 6, , , et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999; 91: 1487–1491.
- 7, , , . The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993; 329: 326–331.
- 8, , . Are increasing 5-year survival rates evidence of success against cancer? JAMA. 2000; 283: 2975–2978.
- 9, . Survivorship analysis for clinical studies. New York: Marcel Dekker, 1991.
- 10, . Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol. 2002; 20: 3302–3316.
- 11, , . The natural history of the development of obesity in a cohort of young US adults between 1981 and 1998. Ann Intern Med. 2002; 136: 857–864.
- 12, . Tumor biology and prognosis in black breast cancer patients: a review. Cancer Detect Prev. 2001; 25: 16–31.
- 13. Racial differences in the response to drugs–pointers to genetic differences. N Engl J Med. 2001; 344: 1393–1395.
- 14, , , et al. Cancer statistics for African Americans. CA Cancer J Clin. 2002; 52: 326–341.Direct Link:
- 15
- 16, , , . Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs Medical System. N Engl J Med. 1993; 329: 621–627.
- 17, , , , . Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med. 2001; 344: 1443–1449.
- 18, . Why is breast cancer mortality declining? Lancet Oncol. 2003; 4: 251–254.
- 19, , . The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control. 1991; 2: 67–74.
- 20, . Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer? Surgery. 1995; 118: 118–120.
- 21, . How much of the recent rise in breast cancer incidence can be explained by increase in mammography utilization? Am J Epidemiol. 1992; 136: 1423–1436.
- 22, , . Inequalities in breast cancer care and outcome. Br J Cancer. 1997; 76: 634–638.
- 23, , , et al. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer. 2001; 37: 1659–1667.
- 24, , , , . Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet. 1995; 345: 1251–1252.
- 25, . Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. BMJ. 1996; 312: 145–148.
- 26. Declining breast cancer mortality: what's behind it? J Natl Cancer Inst. 1999; 91: 750–753.
- 27Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1992; 339: 1–15, 71.
- 28, , , et al. Adjuvant systemic therapy and survival after breast cancer. N Engl J Med. 1994; 330: 805–810.
- 29, , . Race, treatment, and long-term survival from prostate cancer in an equal-access medical delivery system. JAMA. 1995; 274: 1599–1605.
- 30, , . Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer. 1998; 82: 1310–1318.Direct Link:

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)